5-(5-Aryl-1,3,4-oxadiazole-2-carbonyl)furan-3-carboxylate and new cyclic C-glycoside analogues from carbohydrate precursors with MAO-B, antimicrobial and antifungal activities

Article abstract of DOI:10.3390/molecules17067010

Cyclization of acyclic C-glycoside derivatives 1a, b to 2a, b as the major isomers, and 4a, b as the minor isomers were carried out. The isopropylidene derivatives 3a, b were prepared, as well as the hydrazide derivative 6, which was condensed with a variety of aldehydes to give hydrazones 7a-e which were also prepared from the compounds 12a-e. Acetylation of 7a, d gave the corresponding acetyl derivatives 8a, d, respectively. In addition, the dicarbonyl compound 9 was prepared in the hydrate form, which reacted with a number of aroylhydrazines to give the corresponding bisaroylhydrazones 10a-d, which were cyclized into 1,3,4-oxadiazoles 11a-d. Furthermore, two of the prepared compounds were examined to show the ability to activate MAO-B. In addition a number of prepared compounds showed antibacterial and antiviral activities.

Full text of DOI:10.3390/molecules17067010

Molecules 2012, 17, 7010-7027; doi:10.3390/molecules17067010
OPEN ACCESS
molecules
ISSN 1420-3049
www.mdpi.com/journal/molecules
Article
5-(5-Aryl-1,3,4-oxadiazole-2-carbonyl)furan-3-carboxylate
and New Cyclic C-Glycoside Analogues from
Carbohydrate Precursors with MAO-B,
Antimicrobial and Antifungal Activities
Mohamed Mohamed El-Sadek 1,*, Seham Yassen Hassan 1, Nagwa Said Abd El-Dayem 1
and Galila Ahmed Yacout 2
1
Chemistry Department, Faculty of Science, Alexandria University, Alexandria 21231, Egypt;
E-Mails: sehamyassen@yahoo.com (S.Y.H.); nagwa_abdeldayem@yahoo.com (N.S.A.E.-D.)
2
Biochemistry Department, Faculty of Science, Alexandria University, Alexandria 21231, Egypt;
E-Mail: galila_69@yahoo.com
* Author to whom correspondence should be addressed; E-Mail: elsadek_mm@yahoo.com;
Tel.: +20-01-006-544-617; Fax: +20-3-593-2488.
Received: 1 April 2012; in revised form: 27 April 2012 / Accepted: 9 May 2012 /
Published: 7 June 2012
Abstract: Cyclization of acyclic C-glycoside derivatives 1a,b to 2a,b as the major
isomers, and 4a,b as the minor isomers were carried out. The isopropylidene derivatives
3a,b were prepared, as well as the hydrazide derivative 6, which was condensed with a
variety of aldehydes to give hydrazones 7a–e which were also prepared from the
compounds 12a–e. Acetylation of 7a,d gave the corresponding acetyl derivatives 8a,d,
respectively. In addition, the dicarbonyl compound 9 was prepared in the hydrate form,
which reacted with a number of aroylhydrazines to give the corresponding bisaroyl-
hydrazones 10a–d, which were cyclized into 1,3,4-oxadiazoles 11a–d. Furthermore, two of
the prepared compounds were examined to show the ability to activate MAO-B. In
addition a number of prepared compounds showed antibacterial and antiviral activities.
Keywords: carbohydrazone; isopropylidene; triazole; oxadiazole; monoamine oxidase-B

Molecules 2012, 17
7011
1. Introduction
C-glycosides have received a great deal of attention from the synthesis and medicinal chemistry
community, due to their increased stability to hydrolysis as well as their presence in a number of
interesting natural products [1]. Furthermore, heterocyclic compounds containing the five-membered
oxadiazole nucleus possess a diversity of useful biological effects. Substituted 1,3,4-oxadiazoles are of
considerable pharmaceutical interest, for instance, 2-amino-1,3,4-oxadiazoles act as muscle relaxants [2]
and show antimitotic activity. Anti-inflammatory [3,4], antimicrobial [4], anti-hepatitis B [5] and
anti-diarrheal activity [6] of some new 1,3,4-oxadiazole derivatives was also reported. Recently
several 1,3,4-oxadiazole derivatives were identified as potentially active antimycobacterial [7,8],
antitubercular [9], anticonvulsant [10] and anticancer [11] agents, and also reported as enzyme
tyrosinase inhibitors [12]. In light of these interesting biological activities, it became interested in
synthesizing some new C-glycosides of substituted 1,3,4-oxadiazole derivatives and evaluating their
antimicrobial potential.
2. Results and Discussion
2.1. Chemistry
It has been shown [13] that the acid-catalysed, intramolecular dehydration of 1b using conc. HCl (0 °C)
yields a mixture of a major D-ribo anhydro isomer 2b (with inversion of configuration), and a minor
D-arabino-anhydro isomer 4b (with retention of configuration). On the other hand, the dehydration of
1a with aqueous acetic acid (10%) under reflux [14], afforded a mixture of anhydro derivatives 2a
(major isomer) and 4a (the minor one) and in addition, a mixture of 2b and 4b were obtained from 1b
using aqueous acetic acid (10%). The minor isomer 4a could be isolated as a solid.
The anomeric configurations [15] of these anhydro derivatives were ascertained from the 1H-NMR
spectra of their isopropylidene derivatives 3a,b which were prepared by an improved procedure [16]
through treatment of the crude anhydro derivatives with acetone in the presence of catalytic amount of
p-toluenesulphonic acid (see Experimental and Scheme 1).
Scheme 1. Synthesis of isopropylidene derivatives 3a,b.
R
R
R
O
H
H
H
Inversion
O
acetone
R
OH
OH
O
O
HO
H
OH
OH
H
CO
2
+
H
OH
OH
H
2 a,b
3 a,b
H
H2O
R
CH2OH
O
H
OH
OH
acetone
O
No
1
H
H
R
O
O
R
OH
H3C
Inversion
COR'
HO
OCH2
R =
5 a,b
O
4 a,b
a; R' =CH3
b; R' =OC2H5

Molecules 2012, 17
7012
1H-NMR spectra (CDCl3) of compounds 3a,b displayed the two methyl protons signals of the
2,2-dimethyldioxolane ring at δ (1.544–1.352) having Δδ 0.187. The signals of the sugar protons of
1
these isopropylidene derivatives were assigned from the 2D H-NMR spectrum of compound 3b
(Figure 1), and the characteristic chemical shifts as compared with those reported for anhydro
analogues [16], whereby the C-1' proton appears as a singlet at δ 5.00 (J1',2' = 0.00 Hz). Confirmation
of the anomeric configuration of the isopropylidene derivatives 3a,b can be obtained from the zero
coupling constant value (J1',2' = 0.00 Hz), which is an unequivocal [16,17] proof for the trans
arrangement of the H-1' and H-2' (β-D-configuration) as well as from the Δδ value (0.187) [15,18,19].
Boiling of the crude 2b,4b mixture with hydrazine hydrate resulted in the formation of 6, which upon
condensation with a number of aldehydes afforded the corresponding anhydrohydrazone derivatives
7a–e which were also obtained as only one isomer (inversion of configuration at C-1') by boiling the
compounds 12a–e [20,21] with aqueous acetic acid under reflux. The assignment of the signals for the
sugar protons in the 1H-NMR spectra of compounds 7a–e were based on the 2D 1H-NMR spectrum of
compound 7e. In addition, acetylation of the anhydrohydrazones 7a,d afforded the corresponding
O-acetyl derivatives 8a,d, respectively (see Experimental and Scheme 2).
Figure 1. 2D 1H-NMR spectrum of compound 3b.
O
H-1'
O
H-2'
H-4'
H-4''
CH3
O
H-3'
O
O
O
4', 4''
1', 4'' 3', 4''
3', 4'
2', 3'
1', 2'

Molecules 2012, 17
7013
Scheme 2. Synthesis of carbohydrazone derivatives.
O
H
H
N N CHR''
NH2
NH
N
C
O
O
R''
aq. AcOH
NH
R''CHO
NH2NH2
O
CH3
2,4 b
+
H
(10 %)
HO
H
H
H
OH
OH
H b
O
O
CH3
CH3
O
O
1'
4'
3' 2'
H
a
CH2OH
OH OH
OH OH
6
7a-e
12a-e
7a,d
Ac2O / py.
H
N
C
O
R''
NH
O
CH3
O
OAc OAc
8a,d
O
H3C
a; R'' =
b; R'' = N
N
c; R'' =
d; R'' =
e; R'' =
N
N
C C
H H
O
N
N
O
Br
Periodate oxidation [22] of the prepared anhydro-derivatives 2b,4b, gave the corresponding
dialdehyde in the hemialdal structure 9 [22,23]. Furthermore, condensation of dialdehyde 9 with two
molar equivalents of aroylhydrazines, afforded the corresponding bisaroylhydrazones 10a–d. 1H-NMR
spectra of compounds 10a–d (DMSO-d6), showed the two (NH) protons at δ (11.78–11.55) as two
singlets, followed by the aromatic protons as a multiplet at δ (7.82–7.00), two (CH=N) as a doublet at
7.9 for H(2) and a multiplet at 7.7 for H(1), and the proton at position-4 in the furan ring as a singlet at
6.7 ppm. The methine proton was shown as a doublet at δ 5.1, followed by a multiplet at 4.1 ppm for
the protons of the two methylene groups. Oxidative cyclization of the prepared bisaroylhydrazones
10a–d and a physical and chemical study of the oxidation products, revealed that their properties could
not be reconciled with that of 1,2,3-triazole derivatives C [24–27] but rather was compatible with that
of 1,3,4-oxadiazole derivatives 11a–d, that were obtained in appropriate yields. Infrared spectra of
these compounds showed no enol benzoate group as expected for the 1,2,3-triazole derivatives C, and
showed instead a band at 1,667–1,660 cm−1, which was attributed to the conjugated carbonyl group of
compounds 11a–d (see Experimental and Schemes 3 and 4).
1
Furthermore, H-NMR spectra (CDCl3) of these products showed the disappearance of signals
corresponding to two (NH) and two (CH=N), methine and methylene protons. Indeed, it is noteworthy
that the integration of the aromatic part (δ 8.22–7.36 ppm), referred to one aromatic ring only, in
accord with structures 11a,b,d. In addtion, these oxidative cyclization products displayed the proton at
position-4 in the furan ring as the most downfield signal at δ (8.49–8.48) ppm; this proton resonated at
a lower field region than that expected in CDCl3, which may be attributed to the electron withdrawing
effect of the carbonyl group on the neighboring carbon atom, as well as conjugation with the phenyl
oxadiazole moiety. In addition, the structure of the oxidation products 11a–d was further supported

Molecules 2012, 17
7014
through their boiling with hydrochloric acid, which didn’t afford the corresponding amine derivatives D
as expected from 1,2,3-triazole derivatives (see Experimental part and Scheme 4). Moreover, the
proposed mechanism for formation of 11a–d may proceed via elimination of one aroylhydrazone part
(oxidation in presence of iodine and mercuric oxide) due to the bulkiness of the molecule, followed by
oxidative cyclization of the other aroylhydrazone part to afford compounds 11a–d (Scheme 5).
Scheme 3. Synthesis of bisaroylhydrazone derivatives 10a–d.
H
O
O
O
H
H
H
H
O
H
H
O
R
NaIO4
R
R
R
H
HO
CHHC
CHHC
OH
OH
HO
HO
OH
HO OH
O
O
2,4 b
A
B
9
O
O
R =
O
O
CH3
O
O
4
3
O
5
2
O
H
1
CH3
O
H
1
O
+
H
CH3
bH
aH
O
O
6
H
1
H2NHN
R'
2
O
CH 2
N
CH
N
4
3
5
OH
OH
3 HN
NH 4
9
O
O
R'
R'
10a-d
Scheme 4. Synthesis of 1,3,4-oxadiazole derivatives 11a–d.
O
H3C
O
O
C
O
No change
O
N
N
R'
I2 / HgO/
MgO
11a-d
HCl / boil
O
10a-d
H3C
O
O
N
O
H3C
O
O
H
O
N
H
O
N
N
N
O
H
H
O
N
N
HN
O
R'
H
H
R'
R'
D
C
c ;
a ;
R' = H
b ; R' = CH3
R' = OCH3
R' = Cl
d ;

Molecules 2012, 17
Scheme 5. Proposed mechanism for formation of ethyl 2-methyl-5-(5-aryl-1,3,4-
7015
oxadiazole-2-carbonyl)furan-3-carboxylate.
O
O
O
O
O
O
O
O
H3C
O
CH3
O
O
H
O
O
CH3
CH3
I2 / HgO/
MgO
I2 / HgO/ MgO
1
CH 2
N
CH
O
O
R'
CH
C
CH
-2H
O
N
O
3 HN
NH 4
O
N
N
N
N
NH
N
O
R'
O
OH
R'
R'
R'
10a-d
11a-d
c ;
a ;
R' = H
b ; R' = CH3
R' = OCH3
d ; R' = Cl
2.2. Pharmacological Screening
2.2.1. MAO-B Activity
2.2.1.1. Effect of Tested Compounds on MAO-B
This study aimed to evaluate the effect of two selected newly prepared compounds 7c,e on MAO-B
activity given the biological importance of MAO-B [28–38].
2.2.1.2. Determination of Vmax and Km
The Vmax and Km of the MAO-B catalyzed reaction in the presence or absence of each examined
compound was carried out by plotting V against [S], each separately. The obtained results revealed
that MAO-B was activated in the presence of compounds 7c and 7e, each separately, by 6.57- and
6.97-fold, respectively. In addition, the MAO-B catalyzed reactions in the presence of compounds 7c
and 7e have Vmax equal to 0.49 and 0.71, respectively. Meanwhile the Km values were 1.72 and 1.32,
respectively. Our obtained data showed that compound 7e was an effective MAO-B activator, which
increases the affinity of substrate to bind with the active site of MAO-B enzyme. That may be
attributed to the presence of highly conjugated system with the cinamyl group in 7e as compared with
bulky furan ring in 7c (Table 1, Figure 2).
Table 1. Effect of substrate concentration on the rate of MAO-B catalyzed reactions in
presence of the examined compounds 7c and 7e, compared to control.
Rate
Substrate conc.
Control
0.020
0.042
0.050
0.180
0.200
0.280
0.365
0.380
7c
7e
0.25 × 10−3
0.50 × 10−3
1.00 × 10−3
1.50 × 10−3
2.00 × 10−3
3.00 × 10−3
4.00 × 10−3
5.00 × 10−3
0.068
0.085
0.151
0.250
0.322
0.430
0.481
0.498
0.222
0.240
0.315
0.363
0.440
0.560
0.674
0.700

Molecules 2012, 17
Figure 2. Effect of substrate concentration on the rate of MAO-B catalyzed reactions in the
7016
presence of the examined compounds 7c,e compared to control.
2.2.2. Antibacterial and Antifungal Activities
The compounds 3b, 6, 7c,e, 10a–c and 11a,b,d have been studied for their antibacterial and
antifungal activities against four bacterial species (Escherichia coli, Bacillus sp., Staphylococcus sp.,
and Sarcina sp.) and six fungal species (Aspergillus niger, Aspergillus fmigatus, Alternaria sp.,
Fusarium sp., Chaetomium sp., and Penicillium sp.) using the Nutrient Agar (NA) and Sabouraud
Dextrose Agar (SDA) diffusion methods, respectively, in DMSO solvent (Table 2).
Table 2. Inhibition zones of tested compounds against selected microorganisms (mm).
Bacteria
Compound No.
Gram positive
Gram negative
Bacillus sp. Sarcina sp. Staphylococcus sp.
E. coli
….
3b
6
….
….
….
….
….
….
….
….
….
….
….
….
….
….
….
….
….
….
….
….
….
2
….
7c
0.5
2
….
7e
….
10a
10b
10c
11a
11b
11d
….
….
….
1
….
….
….
….
….
….
….
….
Fungi
Compound No.
Aspergillus Aspergillus
Alternaria
Fusarium Chaetomium Penicilliu
niger
1
fumigatus
sp.
….
1
sp.
2
sp.
….
2
sp.
….
2
3b
6
1
….
….
1

Molecules 2012, 17
7017
Table 2. Cont.
Fungi
Compound No.
Aspergillus Aspergillus
Alternaria
Fusarium Chaetomium Penicilliu
niger
1
fumigatus
sp.
sp.
2
sp.
….
….
….
….
….
….
….
….
sp.
0.5
1
7c
1
0.5
7e
….
….
1
2.5
….
….
….
….
….
….
0.5
2
10a
10b
10c
11a
11b
11d
….
….
….
….
….
….
2
….
….
….
2
….
1
….
0.5
….
….
0.5
….
….
….
….
….: No effect.
It was found that they were active against Gram positive bacteria (Staphylococcus sp.). In addition,
the replacement of the bulky furan ring in compound 7c by the cinamyl group in compound 7e,
increased the antibacterial activity against Gram positive bacteria (Staphylococcus sp.), due to the
conjugation caused by the cinamyl group [39]. With respect to antifungal activity, the compounds 3b,
6, 7c,e, and 11a were found to be generally active against the tested fungi.
3. Experimental
3.1. Chemistry
Melting points were determined with a Melt-temp. apparatus and are uncorrected. TLC was
performed on Baker-Flex silica gel 1B-F plates and the spots were detected by UV light absorption. IR
1
1
spectra were recorded on Perkin Elmer. USA Spectrometer. H-NMR, 13C-NMR, and 2D H-NMR
were recorded on a JEOL JNM ECA 500 MHz instrument using tetramethylsilane as an internal
standard. Mass spectra were recorded on GCMS solution DI Analysis Shimadzu Qp-2010 Plus.
Optical rotation was obtained at 22 °C with a Perkin-Elmer Model 241 Polarimeter 10 cm, 1 mL
microcell. Microanalyses were performed at the faculty of Science, Cairo University, Cairo, Egypt.
Solutions were evaporated under diminished pressure unless otherwise stated. The ChemDraw-Ultra-8.0
has been used in generating the nomenclature of the prepared compounds.
3.1.1. Ethyl 5-(2',3'-Dihydroxytetrahydrofuran-1'-yl)-2-methylfuran-3-carboxylates 2b,4b
Compound 1b (15.0 g, 54.74 mmol) was boiled under reflux with aqueous acetic acid (300 mL, 10%)
for 5 h, while the reaction was monitored by TLC (chloroform-methanol, 20:1, V/V), the starting
material disappeared and a more mobile spot (Rf: 0.5) was obtained. The solvent was evaporated under
diminished pressure and washed with toluene (3 times, 10 mL each) to obtain 2b as a yellow thick
syrup along with a solid mass of 4b. Separation of 4b from the syrup was carried out by washing the
mixture with ethanol where it was partially soluble in ethanol on cold; the overall yield was 69.7%; the
solid mass was recrystallized from ethanol as colourless needles; IR (KBr): 3,426 (OH), 1,712 cm−1
(CO-ester).

Molecules 2012, 17
7018
3.1.2. Synthesis of Isopropylidene Derivatives
General Methods. A solution of 2a,4a [22] or 2b,4b mixture (4.42 mmol) in dry acetone (100 mL)
was treated with p-toluenesulphonic acid (10.98 mmol) and stirred at room temperature. The reaction
mixture was monitored by TLC (hexane-ethyl acetate, 7:1, V/V), the starting material disappeared
after 7 h and a more mobile spot appeared. The mixture was then poured onto a saturated solution of
sodium bicarbonate, extracted with chloroform, the organic layer washed with water and dried over
anhydrous sodium sulphate. Evaporation of the dried filtrate gave pale yellow needles.
1-[5-(2',3'-O-Isopropylidene-β-D-erythrofuranosyl)-2-methylfuran-3-yl]ethanone (3a). Yield 51%;
recrystallized from ethanol as colourless needles, mp 97–99 °C; Rf: 0.35 (hexane-ethyl acetate, 7:1,
1
V/V), IR (KBr): 1,682 (CO-acetyl), 1,604, 1,571 cm−1 (C=C); H-NMR (CDCl3); δ: 1.358, 1.544 (2s,
6H, CMe2, Δδ 0.187), 2.376 (s, 3H, COCH3), 2.559 (s, 3H, CH3(furan)), 3.909 (dd, 1H, H-4'a,
J
3',4'a = 3.85 Hz, J4'b,4'a = 10.70 Hz), 4.049 (d, 1H, H-4'b, J4'b,4'a = 10.70 Hz), 4.892–4.937 (m, 2H, H-2',
H-3'), 5.001 (s, 1H, H-1'), 6.475 (s, 1H, CHfuran); MS: m/z (%), 267 (3.50, M++1), 266 (4.82, M+), 137
(36.26), 125 (21.36), 111 (35.32), 109 (21.18), 99 (21.56), 97 (52.51), 95 (33.70), 85 (46.86),
83 (49.75), 81 (32.98), 73 (26.34), 71 (66.24), 69 (61.30), 67 (23.40), 60 (25.40), 57 (100), 56 (21.33),
55 (65.29).
Ethyl 5-(2',3'-O-isopropylidene-β-D-erythrofuranosyl)-2-methylfuran-3-carboxylate (3b). Yield (90%);
recrystallized from ethanol as colourless needles, mp 70–72 °C; Rf: 0.63 (hexane-ethyl acetate, 7:1,
V/V); []2D0 −69.03; IR (KBr): 1,709 (CO-ester) 1,613, 1,583 cm−1 (C=C); 1H-NMR (CDCl3); δ: 1.324
(t, 3H, CH3(ester), J = 6.90 Hz), 1.352, 1.538 (2s, 6H, CMe2, Δδ 0.187), 2.542 (s, 3H, CH3(furan)), 3.870
(dd, 1H, H-4'a, J3',4'a = 3.80 Hz, J4'b,4'a = 10.70 Hz), 4.029 (d, 1H, H-4'b, J4'b,4'a = 10.70 Hz), 4.260 (q,
2H, CH2(ester), J = 6.90 Hz), 4.876–4.928 (m, 2H, H-2', H-3'), 5.003 (s, 1H, H-1'), 6.486 (s, 1H,
CHfuran); MS: m/z (%), 297 (6.3, M++1), 296 (20.6, M+), 182 (100), 181 (30.6), 145 (60), 153 (43),
137 (25), 136 (25.6), 105 (21.3), 80 (27.5), 79 (28.8), 69 (38.1), 65 (28.8), 60 (13.8), 59 (76.3),
56 (25), 55 (30.6), 53 (33.8), 52 (44.4), 51 (60), 50 (25).
5-(2',3'-Dihydroxytetrahydrofuran-1'-yl)-2-methylfuran-3-carbohydrazide (6). A solution of 2b,4b (2.0 g,
7.81 mmol) in ethanol (10 mL) was treated with hydrazine hydrate (4 mL) under reflux for one hour,
while the reaction was monitored by TLC (chloroform-methanol, 6:1, V/V) which revealed the
absence of the starting material and formation of two more mobile spots, Rf: 0.49 (major) and 0.74
(minor). After cooling 6 separated out, was filtered off, washed with a little ethanol, and dried; yield
65%. It was recrystallized from ethanol as colourless needles, mp 185–187 °C. TLC showed one spot
only, Rf: 0.49 (chloroform-methanol, 6:1, V/V); The minor isomer was left in the mother liquor;
1
[]2D0 −58.98; IR (KBr): 3,384, 3,314 (OH and NH2), 3272 (NH), 1,636 cm−1 (CO-amide); H-NMR
(DMSO-d6); δ: 2.463 (s, 3H, CH3(furan)), 3.570 (dd, 1H, H-4'b, J3',4'b = 2.30 Hz, J4'b,4'a = 9.15 Hz), 3.979 (dd,
1H, H-4'a, J3',4'a = 4.60 Hz, J4'b,4'a = 9.15 Hz), 4.029–4.066 (m, 2H, H-3', H-2'), 4.312 (s, 2H, NH2),
4.395 (d, 1H, H-1', J1',2' = 6.90 Hz), 4.985 (d, 1H, 2'-OH, J2',OH = 4.60 Hz), 5.076 (d, 1H, 3'-OH,
J
3',OH = 6.85 Hz), 6.715 (s, 1H, CHfuran), 9.243 (s, 1H, NH). After shaking with D2O, the NH, NH2, and
the two hydroxyl protons disappeared; MS: m/z (%), 243 (2.19, M++1), 242 (16.89, M+), 224 (0.47,

Molecules 2012, 17
7019
M+-H2O), 212 (11.54, M+-2NH), 211 (100, M+-NHNH2); Anal. Calcd for C10H14N2O5: C, 49.58; H,
5.84; N, 1.55%; found: C, 49.58; H, 5.83; N, 1.56%.
3.1.3. Reactions of 6 with a Number of Aldehydes
General Methods
Method A. A solution of 6 (0.5 g, 2.066 mmol) in ethanol (5 mL) containing acetic acid (0.1 mL)
was treated with the corresponding aldehyde (2.066 mmol), and the reaction mixture was refluxed on
water bath for 10 min. After cooling the product 3-carbohydrazone derivative that separated out, was
filtered off, washed with little ethanol, and dried.
Method B. A solution of (1',2',3',4'-tetrahydroxybutyl)furan-3-carbohydrazone 12a–e [20,21]
(4.799 mmol) was refluxed with aqueous acetic acid (10%) for 5 h. After cooling the compounds 7a–e
that separated out as a crystalline mass were filtered off, washed with little ethanol, and dried.
5-(2',3'-Dihydroxytetrahydrofuran-1'-yl)-2-methyl-N-[(2-phenyl-2H-1,2,3-triazol-4-yl)methyl-ene]furan-
3-carbohydrazone (7a). Yield of method A 87%; recrystallized from ethanol as colourless needles, mp
209–210 °C; Rf: 0.39 (chloroform-methanol, 15:1, V/V); []2D0 −37.59; IR (KBr): 3,395 (OH), 3,108
1
(NH), 1,669 (CO-amide), 1,638 cm−1 (C=N); H-NMR (DMSO-d6); δ: 2.524 (s, 3H, CH3(furan)), 3.616
(dd, 1H, H-4'b, J3',4'b = 2.30 Hz, J4'b,4'a = 9.20 Hz), 4.008–4.026 (m, 1H, H-4'a), 4.036–4.095 (m, 2H, H-3',
H-2'), 4.493 (d, 1H, H-1', J1',2' = 6.90 Hz), 5.043 (ss, 1H, 2'-OH), 5.142 (d, 1H, 3'-OH, J3',OH = 6.15 Hz),
6.860 (s, 1H, CHfuran), phenyl protons: 7.432 (t, 1H, p-H), 7.568 (t, 2H, O-H), 8.017 (d, 2H, m-H),
8.401 (s, 1H, CH=N), 8.537 (s, 1H, CHtriazole), 11.610 (s, 1H, NH). After shaking with D2O, the NH
proton and the two hydroxyl protons disappeared; MS: m/z (%), 399 (0.89, M++2), 398 (5.36, M++1),
397 (23.99, M+), 379 (3.55, M+-H2O), 324 (21.85), 253 (11.94, M+-phenyltriazole moiety), 211 (100),
137 (35.81), 77 (20.56, C6H5); Anal. Calcd for C19H19N5O5: C, 57.42; H, 4.80; N, 17.64%; found:
C, 57.43; H, 4.82; N, 17.62%.
N-[(2-(p-Bromophenyl)-2H-1,2,3-triazol-4-yl)methylene]-5-(2',3'-dihydroxytetrahydrofuran-1'-yl)-2-
methylfuran-3-carbohydrazone (7b). Yield of method A 84%; recrystallized from ethanol as colourless
needles, mp 241–243 °C; Rf: 0.38 (chloroform-methanol, 15:1, V/V); []2D0 −31.39; IR (KBr): 3,423
1
(OH), 3,249 (NH), 1,653 (CO-amide), 1,618 cm−1 (C=N); H-NMR (DMSO-d6); δ: 2.519 (s, 3H,
CH3(furan)), 3.617 (dd, 1H, H-4'b, J3',4'b = 2.30 Hz, J4'b,4'a = 9.95 Hz), 4.019 (dd, 1H, H-4'a,
J3',4'a = 3.85 Hz, J4'b,4'a = 9.95 Hz), 4.080–4.109 (m, 2H, H-3', H-2'), 4.493 (d, 1H, H-1', J1',2' = 6.90 Hz),
5.051 (ss, 1H, 2'-OH), 5.147 (d, 1H, 3'-OH, J3',OH = 6.10 Hz), 6.857 (s, 1H, CHfuran), p-bromophenyl
protons: 7.752 (d, 2H, m-H), 7.954 (d, 2H, o-H), 8.422 (s, 1H, CH=N), 8.518 (s, 1H, CH(triazole)),
11.630 (s, 1H, NH). After shaking with D2O, the NH proton and the two hydroxyl protons
13
disappeared; C-NMR; δ: 14.00 (C-13), 70.91 (C-4'), 73.32 (C-3'), 75.33 (C-2'), 76.50 (C-1'), 107.79
(C-12), 115.11 (C-11), 120.92 (C-10), 121.23 (C-9), 133.27 (C-8), 135.16 (C-7), 137.74 (C-6), 138.52
(C-5), 146.50 (C-4), 151.71 (C-3), 158.19 (C-2), 159.84 (C-1); MS: m/z (%), 478/476 (2.03, 2.17,
M++1), 477/475 (8.85, 9.10, M+), 459/457 (1.25, 1.24, M+-H2O), 253 (10.01, M+-p-bromophenyl
triazole moiety), 211 (100), 137 (34); Anal. Calcd for C19H18BrN5O5: C, 47.90; H, 3.83; N, 14.71;
Br, 16.77%; found: C, 47.91; H, 3.81; N, 14.70; Br, 16.78%.

Molecules 2012, 17
7020
Ethyl 5-[(2-(5-(2',3'-dihydroxytetrahydrofuran-1'-yl)-2-methylfuran-3-carbonyl)hydrazono)-methyl]-2-
methylfuran-3-carboxylate (7c). Yield of method A 93%; []2D0 −44.42; IR (KBr): 3,426 (OH), 3,208
(NH), 1,694 (CO-ester), 1,655 (CO-amide), 1,616 cm−1 (C=N); 1H-NMR (DMSO-d6); δ: 1.254 (t, 3H,
CH3(ester), J = 7.65 Hz), 2.501 (s, 3H, CH3(furan-1)), 2.580 (s, 3H, CH3(furan-2)), 3.603 (dd, 1H,
H-4'b, J3',4'b = 2.30 Hz, J4'b,4'a = 9.90 Hz), 4.004 (dd, 1H, H-4'a, J3',4'a = 4.60 Hz, J4'b,4'a = 9.90 Hz),
4.043–4.088 (m, 2H, H-3', H-2'), 4.209 (q, 2H, CH2(ester), J = 7.65 Hz), 4.467 (d, 1H, H-1', J1',2' = 6.85 Hz),
5.028 (d, 1H, 2'-OH, J2',OH = 3.80 Hz), 5.124 (d, 1H, 3'-OH, J3',OH = 6.10 Hz), 6.830 (s, 1H, CHfuran-1),
7.059 (s, 1H, CHfuran-2), 8.150 (s, 1H, CH=N), 11.409 (s, 1H, NH). After shaking with D2O, the NH
proton and the two hydroxyl protons disappeared; MS: m/z (%), 408 (0.79, M++2), 407 (4.16, M++1),
406 (18.26, M+), 211 (100), 154 (32.75); Anal. Calcd for C19H22N2O8: C, 56.13; H, 5.47; N, 6.86%;
found: C, 56.15; H, 5.46; N, 6.89%.
N-Benzylidene-5-(2',3'-dihydroxytetrahydrofuran-1'-yl)-2-methylfuran-3-carbohydrazone (7d). Yield
of method A 84%; recrystallized from ethanol as colourless needles, mp 86–88 °C; Rf: 0.345
(chloroform-methanol, 15:1, V/V); []2D0 −42.16; IR (KBr): 3,380 (OH and NH), 1,661 (CO-amide),
1,616 cm−1 (C=N); 1H-NMR (DMSO-d6); δ: 2.513 (s, 3H, CH3(furan)), 3.608 (dd, 1H, H-4'b, J3',4'b = 2.30 Hz,
J4'b,4'a = 9.95 Hz), 4.012 (dd, 1H, H-4'a, J3',4'a = 4.60 Hz, J4'b,4'a = 9.95 Hz), 4.065–4.089 (m, 2H, H-3',
H-2'), 4.476 (d, 1H, H-1', J1',2' = 6.90 Hz), 5.043 (d, 1H, 2'-OH, J2',OH = 3.85 Hz), 5.141 (d, 1H, 3'-OH,
J3',OH = 6.10 Hz), 6.869 (s, 1H, CH(furan)), phenyl protons: 7.395–7.436 (m, 3H, p-H, O-H), 7.672 (d,
2H, m-H), 8.340 (s, 1H, CH=N), 11.389 (s, 1H, NH). After addition of D2O, the NH proton and the
two hydroxyl protons disappeared; MS: m/z (%), 331 (2.25, M++1), 330 (10.80, M+), 227 (9.18,
M+-C6H5CN), 211 (100), 154 (59.63), 77 (9.32, C6H5); Anal. Calcd for C17H18N2O5: C, 61.80; H, 5.50;
N, 8.45%; found: C, 61.8; H, 5.49; N, 8.48%.
5-(2',3'-Dihydroxytetrahydrofuran-1'-yl)-2-methyl-N-(3-phenylallylidene)furan-3-carbohydrazone (7e).
Yield of method A 92.5%; recrystallized from ethanol as colourless needles, mp 162–163 °C; Rf: 0.78
(chloroform:-methanol, 10:1, V/V); []2D0 −42.55; IR (KBr): 3,409 (OH), 3,241 (NH), 1,657 (CO-amide),
1
1,628 cm−1 (C=N); H-NMR (DMSO-d6); δ: 2.499 (s, 3H, CH3(furan)), 3.598–3.617 (m, 1H, H-4'b),
4.013 (dd, 1H, H-4'a, J3',4'a = 3.80 Hz, J4'b,4'a = 9.90 Hz), 4.026–4.104 (m, 2H, H-3', H-2'), 4.476 (d, 1H,
H-1', J1',2' = 6.90 Hz), 5.025 (d, 1H, 2'-OH, J2',OH = 3.80 Hz), 5.121 (d, 1H, 3'-OH, J3',OH = 6.15 Hz);
6.849 (s, 1H,CHfuran), 7.00 (bs, 2H, CH=CH), phenyl protons: 7.273–7.302 (m, 1H, p-H), 7.355 (t, 2H,
O-H), 7.585 (d, 2H, m-H); 8.124 (d, 1H, CH=N, J = 6.15 Hz), 11.264 (s, 1H, NH); MS: m/z (%), 358
(0.21, M++2), 357 (0.95, M++1), 356 (3.22, M+), 338 (0.11, M+-H2O), 320 (0.21, M+-2H2O), 279
(0.52, M+-C6H5), 211 (100), 154 (55.50), 130 (35.56), 77 (8.65, C6H5), 43 (49, COCH3); Anal. Calcd
for C19H20N2O5: C, 64.03; H, 5.64; N, 7.84%; found: C, 64.04; H, 5.66; N, 7.86%.
3.1.4. Reactions of Compounds 7a,d with Acetic Anhydride
General Method: A solution of the sugar derivative 7a or 7d (1.51 mmol) in a mixture of pyridine
(15 mL) and acetic anhydride (15 mL) was kept overnight at room temperature with occasional
shaking. Then it was poured onto crushed ice, the di-O-acetyl derivative that separated out, was
filtered off, washed with water, and dried.

Molecules 2012, 17
7021
1'-[2-Methyl-3-(2-((2-phenyl-2H-1,2,3-triazol-4-yl)methylene)hydrazinecarbonyl)furan-5-yl]-tetra-hydro
furan-2',3'-diyl diacetate (8a). Yield 76.5%; recrystallized from dilute ethanol as colourless needles,
mp 179–181 °C; Rf 0.5 (hexane-ethyl acetate, 2:1, V/V); []2D0 −47.75; IR (KBr): 3,217 (NH), 1,754
1
(OAc), 1,647 (CO-amide), 1,601 cm−1 (C=N); H-NMR (CDCl3); δ: 2.061, 2.139 (2s, 6H, 2OAc),
2.677 (s, 3H, CH3(furan)), 3.984–3.968 (m, 1H, H-4'b), 4.371 (dd, 1H, H-4'a, J3',4'a = 4.60 Hz,
J
4'b,4'a = 9.95 Hz), 4.925 (d, 1H, H-1', J1',2' = 6.10 Hz), 5.492–5.532 (m, 2H, H-3', H-2'), 6.744 (bs, 1H,
CHfuran), 7.462–7.478 (m, 1H, p-H), 7.531–7.625 (m, 2H, O-H), 8.019–8.141 (m, 4H, m-H, CH=N,
CHtriazole), and 12.239 (s, 1H, NH); MS: m/z (%), 482 (0.61, M++1), 481 (1.97, M+), 363 (22.58), 362
(100), 295 (67.47), 137 (21.53), 115 (19.79), 77 (15.78); Anal. Calcd for C23H23N5O7: C, 57.35; H,
4.82; N, 14.53%; found: C, 57.38; H, 4.82; N, 14.55%.
1'-[3-(2-Benzylidenehydrazinecarbonyl)-2-methylfuran-5-yl]tetrahydrofuran-2',3'-diyl diacetate (8d).
Yield 80%; recrystallized from dilute methanol as colourless needles, mp 81–82 °C; Rf 0.5 (hexane-ethyl
acetate, 2:1, V/V); []2D0 −48.37; IR (KBr): 3,248 (NH), 1,752 (OAc), 1,654 (CO-amide), 1,582 cm−1
1
(C=N); H-NMR (CDCl3); δ: 2.070, 2.125 (2s, 6H, 2OAc), 2.602 (s, 3H, CH3(furan)), 3.954–3.974 (m,
1H, H-4'b), 4.381–4.350 (m, 1H, H-4'a), 4.950 (bs, 1H, H-1'), 5.417–5.524 (m, 2H, H-3', H-2'), 6.620
(s, 1H, CHfuran), 7.519–7.549 (m, 5H, phenyl protons), 7.883 (d, 1H, CH=N, J = 7.65 Hz), 9.550 (s,
1H, NH); MS: m/z (%), 415 (0.39, M++1), 414 (0.81, M+), 295 (100), 77 (2.61); Anal. Calcd for
C21H22N2O7: C, 60.86; H, 5.37; N, 6.77%; found: C, 60.86; H, 5.35; N, 6.76%.
Ethyl 5-(3,5-dihydroxy-1,4-dioxan-2-yl)-2-methylfuran-3-carboxylate (9). A solution of 2b,4b mixture
(12.96 g, 50.62 mmol) in distilled water (20 mL) was treated dropwise with a solution of sodium
metaperiodate (10.825 g, 50.62 mmol) in distilled water (20 mL) with continuous stirring for 3 h. The
dialdehyde that separated out was filtered off, washed with little water, and dried, yield 67%; Rf: 0.38
(chloroform-methanol, 15:1, V/V). Recrystallized from ethanol as colourless needles, mp 111–113 °C
(Lit. [22], 111–113 °C); IR (KBr): 3,426 (OH), 1,712 cm−1 (CO-ester); 1H-NMR (CDCl3); δ: 1.293–1.326
(m, 3H, CH3(ester)), 2.519 (s, 3H, CH3(furan)), 3.380–3.428 (m, 1H, H-6b), 3.745–3.947 (m, 1H, H-6a),
4.222–4.387 (m, 2H, 3-OH, 5-OH), 4.275 (q, 2H, CH2(ester)), 4.609–4.745 (m, 1H, H-5), 5.112–5.125
(m, 1H, H-3), 5.514–5.534 (m, 1H, H-2), and 6.677 (s, 1H, CHfuran).
3.1.5. Reactions of 9 with a Number of Aroylhydrazines
General Method: A solution of 9 (2.0 g, 7.353 mmol) in ethanol (10 mL) containing acetic acid
(0.1 mL) was treated with the corresponding aroylhydrazine (14.71 mmol) in ethanol (10 mL). The
reaction mixture was refluxed on water bath for 15 min, the bisaroylhydrazone derivative that
separated out was filtered off, washed with little ethanol, and dried.
Ethyl
5-[2-(2-benzoylhydrazono)-1-(2-(2-benzoylhydrazono)ethoxy)ethyl]-2-methylfuran-3-carboxylate
(10a). Yield 61%; recrystallized from ethanol-chloroform as colourless needles, mp 204–206 °C; Rf:
0.55 (chloroform-methanol, 10:1, V/V); IR (KBr): 3,280, 3,197 (2NH), 1,715 (CO-ester), 1,658
(CO-amide), 1,591 cm−1 (C=N); 1H-NMR (DMSO-d6); δ: 1.223 (t, 3H, CH3(ester), J = 6.90 Hz ), 2.524
(s, 3H, CH3(furan)), 4.086–4.199 (m, 4H, CH2, CH2(ester)), 5.150 (d, 1H, CH, J = 6.85 Hz), 6.736 (s, 1H,
CHfuran), phenyl protons: 7.472–7.476 (m, 4H, O-H), 7.550–7.546 (m, 2H, p-H), 7.794–7.837 (m, 4H,

Molecules 2012, 17
7022
m-H), 7.719 (bs, 1H, CH=N1), 7.912 (d, 1H, CH=N2, J = 6.10 Hz), 11.673 (s, 1H, NH3), 11.777 (s, 1H,
NH4); MS: m/z (%), 472 (0.57, M+-H2O), 354 (56.88), 181 (31.16), 173 (29.44), 153 (23.60), 147
(93.31), 121 (41.45), 106 (49.34), 105 (100), 104 (23.78), 78 (21.08), 77 (99.13), 51 (77.47), 50
(24.02); Anal. Calcd for C26H26N4O6: C, 63.65; H, 5.35; N, 11.43%; found: C, 63.66; H, 5.34; N, 11.42%.
Ethyl 5-[2-(2-(p-toluoyl)hydrazono)-1-(2-(2-(p-toluoyl)hydrazono)ethoxy)ethyl]-2-methylfuran-3-carboxylate
(10b). Yield 58%; recrystallized from ethanol-chloroform as colourless needles, mp 204–206 °C; Rf:
0.22 (chloroform-methanol, 15:1, V/V); IR (KBr): 3,305, 3,183 (2NH), 1,717 (CO-ester), 1,651
1
(CO-amide), 1,625, 1,612 cm−1 (C=N); H-NMR (DMSO-d6); δ: 1.222 (t, 3H, CH3(ester), J = 6.85 Hz),
2.327 (s, 6H, 2CH3(toluoyl)), 2.522 (s, 3H, CH3(furan)), 4.103–4.196 (m, 4H, CH2, CH2(ester)), 5.132 (d, 1H,
CH, J = 6.90 Hz), 6.727 (s, 1H, CHfuran), aromatic protons: 7.265–7.280 (m, 4H, O-H), 7.708–7.747(m,
5H, m-H, CH=N1), 7.899 (d, 1H, CH=N2, J = 6.10 Hz), 11.601 (s, 1H, NH3), 11.716 (s, 1H, NH4); MS:
m/z (%), 518 (0.09, M+), 500 (0.18, M+-H2O), 368 (31.86), 161 (44.53), 161 (44.53), 119 (100), 91
(50.53), 65 (19.49); Anal. Calcd for C28H30N4O6: C, 64.87; H, 5.85; N, 10.78%; found: C, 64.85;
H, 5.83; N, 10.80%.
Ethyl
5-[2-(2-(p-anisoyl)hydrazono)-1-(2-(2-(p-anisoyl)hydrazono)ethoxy)ethyl]-2-methylfuran-3-
carboxylate (10c). Yield 57%; recrystallized from ethanol-chloroform as colourless needles, mp
204–206 °C; Rf: 0.32 (chloroform:-methanol, 10:1, V/V); IR (KBr): 3,268, 3,212 (2NH), 1,718 (CO-ester),
1
1,645 (CO-amide), 1,610 cm−1 (C=N); H-NMR (DMSO-d6); δ: 1.225 (t, 3H, CH3(ester), J = 6.15 Hz),
2.525 (s, 3H, CH3(furan)), 3.776 (s, 6H, 2OCH3), 4.156–4.199 (m, 4H, CH2, CH2(ester)), 5.127 (d, 1H,
CH, J = 6.15 Hz), 6.726 (s, 1H, CHfuran), aromatic protons: 6.700–7.008 (m, 4H, m-H), 7.799–7.837
(m, 4H, O-H), 7.707 (bs, 1H, CH=N1), 7.895 (d, 1H, CH=N2, J = 6.10 Hz), 11.554 (s, 1H, NH3),
11.653 (s, 1H, NH4); MS: m/z (%), 532 (0.15, M+-H2O), 135 (100); Anal. Calcd for C28H30N4O8:
C, 61.05; H, 5.47; N, 10.19%; found: C, 61.08; H, 5.49; N, 10.18%.
Ethyl
5-[2-(2-(p-chlorobenzoyl)hydrazono)-1-(2-(2-(p-chlorobenzoyl)hydrazono)ethoxy)ethyl]-2-
methylfuran-3-carboxylate (10d). Yield 62%; recrystallized from ethanol-chloroform as colourless
needles, mp 204–206 °C; Rf: 0.4 (chloroform-methanol, 15:1, V/V); IR (KBr): 3,270, 3,215 (2NH),
1,719 (CO-ester), 1,650 (CO-amide), 1,612 cm−1 (C=N); Anal. Calcd for C26H24Cl2N4O6: C, 55.80;
H, 4.33; N, 10.02; Cl, 12.69%; found: C, 55.82; H, 4.32; N, 10.02; Cl, 12.68%.
3.1.6. Reactions of Compounds 10a–d with Yellow Mercuric Oxide
General Method: A solution of 10a–d (4.5 mmol) in dry ether (50 mL) was stirred with yellow
mercuric oxide (3.0 g), magnesium oxide (0.3 g), and iodine (2.5 g) at room temperature for 48 h
under anhydrous condition. The reaction mixture was filtered off, and the filtrate washed with
potassium iodide solution, sodium thiosulphate, and water, respectively, then dried over anhydrous
sodium sulphate. On evaporation of the dried filtrate a yellow syrup was obtained, which was
crystallized from ethanol. An additional crop was obtained by extracting the inorganic residue with
chloroform which upon concentration and dilution with ethanol yielded the same product.

Molecules 2012, 17
7023
Ethyl 2-methyl-5-(5-phenyl-1,3,4-oxadiazole-2-carbonyl)furan-3-carboxylate (11a). Yield 36%;
recrystallized from ethanol as colourless needles, mp 168–170 °C; Rf: 0.41 (hexane-ethyl acetate, 6:1,
1
V/V); IR (KBr): 1,715 (CO-ester), 1,660 (C=O), 1,594 cm−1 (C=N); H-NMR (CDCl3); δ: 1.391 (t,
3H, CH3(ester), J = 6.85 Hz), 2.778 (s, 3H, CH3(furan)), 4.344 (q, 2H, CH2(ester), J = 6.85 Hz), phenyl
protons: 7.565 (t, 2H, O-H), 7.611–7.637 (m, 1H, p-H), 8.210–8.224 (m, 2H, m-H), 8.491 (s, 1H,
CHfuran); MS: m/z (%), 328 (3.07, M++2), 327 (20.48, M++1), 326 (100, M+), 181 (22.15), 153 (32.73),
145 (61.44), 77 (49.04); Anal. Calcd for C17H14N2O5: C, 62.57; H, 4.32; N, 8.59%; found: C, 62.57;
H, 4.33; N, 8.60%.
Ethyl 2-methyl-5-(5-(p-tolyl)-1,3,4-oxadiazole-2-carbonyl)furan-3-carboxylate (11b). Yield 39%;
recrystallized from ethanol as colourless needles, mp 185–187 °C; Rf: 0.52 (hexane-ethyl acetate, 6:1,
1
V/V); IR (KBr): 1,715 (CO-ester), 1,660 (C=O), 1,611 cm−1 (C=N); H-NMR (CDCl3); δ: 1.390 (t,
3H, CH3(ester), J = 6.90 Hz), 2.457 (s, 3H, CH3(tolyl)), 2.775 (s, 3H, CH3(furan)), 4.348 (q, 2H, CH2(ester)
,
J = 6.90 Hz), phenyl protons: 7.361 (d, 2H, O-H), 8.098 (d, 2H, m-H), 8.482 (s, 1H, CHfuran); Anal.
Calcd for C18H16N2O5: C, 63.53; H, 4.76; N, 8.25%; found: C, 63.52; H, 4.74; N, 8.23%.
Ethyl 2-methyl-5-[5-(p-anisyl)-1,3,4-oxadiazole-2-carbonyl]furan-3-carboxylate (11c). Yield 21%;
recrystallized from ethanol as colourless needles, mp 182–183 °C; Rf: 0.41 (hexane-ethyl acetate, 6:1,
V/V); IR (KBr): 1,714 (CO-ester), 1,657 (C=O), 1,606 cm−1 (C=N); Anal. Calcd for C18H16N2O6:
C, 60.66; H, 4.55; N, 7.86%; found: C, 60.67; H, 4.53; N, 7.86%.
Ethyl 2-methyl-5-[5-(p-chlorophenyl)-1,3,4-oxadiazole-2-carbonyl]furan-3-carboxylate (11d). Yield
39%; recrystallized from ethanol as colourless needles, mp 177–178 °C; Rf: 0.59 (hexane-ethyl
1
acetate, 6:1, V/V); IR (KBr): 1,723 (CO-ester), 1,667 (C=O), and 1,600 cm−1 (C=N); H-NMR
(CDCl3); δ: 1.391 (t, 3H, CH3(ester), J = 6.85 Hz), 2.778 (s, 3H, CH3(furan)), 4.353 (q, 2H, CH2(ester)
,
J = 6.85 Hz), p-chlorophenyl protons: 7.550 (d, 2H, m-H), 8.158 (d, 2H, O-H), 8.482 (s, 1H, CHfuran);
1H-NMR (DMSO-d6); δ: 1.293 (t, 3H, CH3(ester), J = 6.85 Hz), 2.692 (s, 3H, CH3(furan)), 4.269 (q, 2H,
CH2(ester), J = 6.85 Hz), p-chlorophenyl protons: 7.700 (d, 2H, m-H), 8.082 (d, 2H, O-H), 8.170 (s, 1H,
CHfuran); MS: m/z (%), 362/360 (100, 42, M+), 181 (78.7), 179 (71.29), 153 (78.02), 141/139 (11.12,
33.56), 137 (39.6), 113/111 (10.89, 33.86); Anal. Calcd for C17H13ClN2O5: C, 56.62; H, 3.64; N, 7.75;
Cl, 9.81%; found: C, 56.60; H, 3.63; N, 7.77; Cl, 9.83%.
3.2. Pharmacological Screening
3.2.1. MAO-B Activity
3.2.1.1. Enzyme Preparation
Rabbit brain was homogenized in 9 volumes of ice-cold 0.1 M sodium phosphate buffer (pH 7.4)
with an Ultra-Turrax 18/2 homogenizer. The separated mitochondrial fraction was suspended in
phosphate buffer to give a final volume of 1 mL g−1 weight of tissue [40].

Molecules 2012, 17
7024
3.2.1.2. Enzyme Assay
Monoamine oxidase-B activity was assayed in presence and absence of the examined compounds
each separately using benzylamine as substrate by continuous recording on a Pye Unicam SP8-100
Double Beam Spectrophotometer of the increase in extinction at 250 nm produced at 38 °C.
3.2.1.3. Determination of Vmax and Km
The Vmax and Km of MAO-B catalyzed reaction in presence or absence of each examined compound
7c and 7e was carried out by plotting the rate of the reaction (V) against substrate concentration [S],
each separately.
3.2.2. Antibacterial and Antifungal Screening
The antibacterial and antifungal activities of synthesized compounds 3b, 6, 7c,e, 10a–c and 11a,b,d
against four bacterial species (Escherichia coli, Bacillus sp., Staphylococcus sp., and Sarcina sp.) and
six fungal species (Aspergillus niger, Aspergillus fmigatus, Alternaria sp., Fusarium sp., Chaetomium
sp., and Penicillium sp.). have been studied by using the Nutrient Agar (NA) and Sabouraud Dextrose
Agar (SDA) diffusion methods, respectively in DMSO solvent. The bacteria were subcultured on
Nutrient Agar medium (NA), whereas, fungi were subcultured on Sabouraud Dextrose Agar (SDA).
The composition is given in g/L unless otherwise stated. The pH value of the media was adjusted to
7 ± 0.1 prior to sterilization with 0.1 M sodium hydroxide or hydrochloric acid. All media were
prepared with distilled water and sterilized by autoclaving at 121 °C for 20 min. Nutrient Agar (NB):
Peptone, 5; beef extract, 3; NaCl, 5; agar, 20. Sabouraud Dextrose Agar (SDA): Peptone, 10; glucose,
40; agar, 20. The stock solutions (1 mg/mL) of the test chemicals were prepared by dissolving 10 mg
of the test compounds in 10 mL dimethylsulphoxide (DMSO) solvent. Petri plates (150 mm × 15 mm)
were prepared by pouring 60 mL of SDA and allowed to solidify. Plates were dried and 1 mL of each
standardized inoculums suspension was poured and uniformly spread. The excess inoculums was
drained and the inoculums was allowed to dry for 15 min. Eight equidistant wells were made in the
medium using a sterile cork borer (6 mm in diameter and 50 μL of the test chemicals (1 mg/mL)
diluted in DMSO 2% were placed into the wells. The Petri-dishes containing bacterial and fungi
species were incubated at 37 °C for 24 h, and 48 h, respectively. The tests were carried in triplicate.
The antimicrobial activity was measured as the diameter (mm) of clear zone of growth inhibition.
4. Conclusions
Some new C-glycoside derivatives and heterocyclic derivatives of carbohydrate have been prepared
and their physical and biological properties were studied. It was found that compounds with highly
conjugated systems are acting as MAO-B activators, as well as antibacterial agents, meanwhile all
tested compounds have antifungal activities.

Molecules 2012, 17
7025
Acknowledgments
Thanks are due to Sallam, M.A., Faculty of Science, Alexandria University for optical rotation
measurements, and El-Badn, D., Department of Botany, Faculty of Science, Alexandria University for
microbiological studies.
References and Notes
1. Rainier, J.D.; Cox, J.M. Aluminum- and boron-mediated C-glycoside synthesis from 1,2-anhydro-
glycosides. Org. Lett. 2000, 2, 2707–2709.
2. Yale, H.L.; Losee, K. 2-Amino-5-substituted 1,3,4-oxadiazoles and 5-imino-2-substituted
Δ2-1,3,4-oxadiazolines. A group of novel muscle relaxants. J. Med. Chem. 1966, 9, 478–483.
3. Omar, F.A.; Mahfouz, N.M.; Rahman, M.A. Design, synthesis and anti-inflammatory activity of
some 1,3,4-oxadiazole derivatives. Eur. J. Med. Chem. 1996, 31, 819–825.
4. Palusa, S.K.G.; Udupi, R.H.; Himabindu, V.; Sridhara, A.M. Synthesis and evaluation of a series
of pyrimidine substituted 1,3,4-oxadiazole derivatives as antimicrobial and anti-inflammatory
agents. Org. Commun. 2011, 4, 82–93.
5. Tan, T.M.C.; Chen, Y.; Kong, K.H.; Bai, J.; Li, Y.; Lim, S.G.; Ang, T.H.; Lam, Y. Synthesis and
the biological evaluation of 2-benzenesulfonyl alkyl-5-substituted-sulfanyl-(1,3,4)-oxadiazoles as
potential anti-hepatitis B virus agents, Antiviral Res. 2006, 71, 7–14.
6. Adelstein, G.W.; Yen, C.H.; Dajani, E.Z.; Bianchi, R.G. 3,3-Diphenyl-3-(2-alkyl-1,3,4-oxadiazol-
5-yl)propylcycloalkylamines, a novel series of antidiarrheal agents, J. Med. Chem. 1976, 19,
1221–1225.
7. Jha, K.K.; Samad, A.; Kumar, Y.; Shaharyar, M.; Khosa, R.; Jain, J.; Bansal, S. 3D-QSAR studies
of 1,3,4-oxadiazole derivatives as antimycobacterial agents. Iran. J. Pharm. Res. 2009, 8, 163–167.
8. Macaev, F.; Rusu, G.; Pogrebnoi, S.; Gudima, A.; Stingaci, E.; Vlad, L.; Shvets, N.; Kandemirli, F.;
Dimoglo, A.; Reynolds, R. Synthesis of novel 5-aryl-2-thio-1,3,4-oxadiazoles and the study of
their structure-anti-mycobacterial activities. Bioorg. Med. Chem. 2005, 13, 4842–4850.
9. Navarrete-Vazquez, G.; Molina-Salinas, G.M.; Duarte-Fajardo, Z.V.; Vargas-Villarreal, J.;
Estrada-Soto, S.; Gonzalez-Salazar, F.; Hernandez-Nunez, E.; Said-Fernandez, S. Synthesis and
antimycobacterial activity of 4-(5-substituted-1,3,4-oxadiazol-2-yl)pyridines, Bioorg. Med. Chem.
2007, 15, 5502–5508.
10. Zarghi, A.; Tabatabai, S.A.; Faizi, M.; Ahadian, A.; Navabi, P.; Zanganeh, V.; Shafiee, A.
Synthesis and anticonvulsant activity of new 2-substituted-5-(2-benzyloxyphenyl)-1,3,4-oxadiazoles.
Bioorg. Med. Chem. Lett. 2005, 15, 1863–1865.
11. Jin, L.; Chen, J.; Song, B.; Chen, Z.; Yang, S.; Li, Q.; Hu, D.; Xu, R. Synthesis, structure, and
bioactivity of N'-substituted benzylidene-3,4,5-trimethoxybenzohydrazide and 3-acetyl-2 substituted
phenyl-5-(3,4,5-trimethoxyphenyl)-2,3-dihydro-1,3,4-oxadiazole derivatives. Bioorg. Med. Chem.
Lett. 2006, 16, 5036–5040.
12. Sawant, R.; Lanke, P.; Jadhav, G.; Bhangale, L. QSAR analysis of structurally similar
1,3,4-oxadiazoles as enzyme tyrosinase inhibitors. Drug Invent. Today 2010, 2, 169–172.

Molecules 2012, 17
7026
13. Sánchez, A.G.; Roldán, A.R. Dehydraion of 2-(D-arabino-tetrahyroxybutyl)furans. Carbohydr. Res.
1972, 22, 53–62.
14. González, F.G. Reactions of monosaccharides with beta-ketonic esters and related substances. In
Advances in Carbohydrate Chemistry; Wolfrom, L.M., Tipson, S.R., Eds.; Academic Press Inc.:
New York, NY, USA, 1956; Volume 11, pp. 97–143.
15. El-Sallam, M.A.; Hegazy, E.I.A. Studies on 3-epimeric 2-hexulose phenylosazones. Structure and
anomeric configuration of the 3,6-anhydro-osazone derivatives obtained from D-arabino- and
D-ribo-2-hexulose phenylosazone. Carbohydr. Res. 1981, 95, 177–188.
16. El-Sallam, M.A.; Ibrahim, E.S.I.; El-Eter, K.A.A.; Cassady, J.M. Synthesis and anomeric
configuration of 2-(erythrofuranosyl)benzimidazole C-nucleoside analogues. Carbohydr. Res.
1997, 298, 93–104.
17. Sable, H.Z.; Ritchey, W.M.; Nordlander, J.E. Studies on cyclic polyols part IV. Nuclear magnetic
resonance spectra and configurational assignments of polyhydroxycyclopentanes. Carbohydr. Res.
1965, 1, 10–21.
18. MacCoss, M.; Robins, M.J.; Rayner, B.; Imbach, J.L. A new aspect of the use of
2',3'-O-isopropylidene ribonucleosides for investigation of anomeric configuration. Carbohydr. Res.
1977, 59, 575–579.
19. Maeba, I.; Iwata, K.; Usami, F.; Furukawa, H. C-Nucleosides 1. Synthesis of 3-(β-D-ribofuranosyl)
pyridazines. J. Org. Chem. 1983, 48, 2998–3002.
20. Hassan, S.Y.; Yaccout, G.A.; Abd El-Dayem, N.S.; El Sadek, M.M. Chemistry Department,
Faculty of Science, Alexandria University, Alexandria, Egypt. Unpublished work, 2009.
21. El Sadek, M.M.; Zagzoug, N.B.; El Soccary, N.N. Reactions of 2-methyl-5-(D-arabino-
tetrahydroxybutyl)-3-furoylhydrazine. Carbohydr. Res. 1993, 250, 323–326.
22. Sánchez, A.G.; Roldán, A.R. Dehydration of 2-(D-arabino-tetrahydroxybutyl)furans. Carbohydr. Res.
1972, 22, 53–62.
23. Guthrie, R.D.; Honeyman, J. Periodate oxidation of methyl 4:6-O-benzylidene--D-glucoside.
Chem. Ind. 1958, 29, 388–389.
24. Alexandrou, N.E. Reassignment of structures of the dihydro-v-tetrazines. II: Mechanism of
oxidation of diacylhydrazones. Tetrahedron 1966, 22, 1309–1316.
25. El Khadem, H.; Shaban, M.A.E. Carbohydrate derivatives of 1-substituted 1,2,3-triazoles.
J. Chem. Soc. C 1967, 1967, 519–520.
26. El-Khadem, H.; Shaban, M.A.E.; Nassr, M.A.M. Oxidation of mesoxalaldehyde bis- and
tris-(benzoylhydrazones). J. Chem. Soc. C 1969, 1969, 1416–1418.
27. El-Khadem, H.; El-Sadik, M.M.; Meshreki, M.H. Reactions of phenylglyoxal bisarylhydrazones.
J. Chem. Soc. C 1968, 1968, 2097–2099.
28. Ni, X.; Chan, D.; Chan, K.; McMain, S.; Kennedy, J.L. Serotonin genes and gene-gene interactions
in borderline personality disorder in a matched case-control study. Prog. Neuropsychopharmacol.
Biol. Psychiatry 2009, 33, 128–133.
29. Upadhyay, A.K.; Edmondson, D.E. Characterization of detergent purified recombinant rat liver
monoamine oxidase B expressed in Pichia pastoris. Protein Expr. Purif. 2008, 59, 349–356.
30. Setini, A.; Pierucci, F.; Senatori, O.; Nicotra, A. Molecular characterization of monoamine
oxidase in zebrafish (Danio rerio). Comp. Biochem. Physiol. 2005, 140, 153–161.

Molecules 2012, 17
7027
31. Kaneda, Y.; Fujii, A.; Nagamine, I. Platelet serotonin concentrations in medicated schizophrenic
patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 2001, 25, 983–992.
32. Garpenstrand, H.; Longato-Stadler, E.; Klinteberg, B.A.; Grigorenko, E.; Damberg, M.; Oreland, L.;
Hallman, J. Low platelet monoamine oxidase activity in Swedish imprisoned criminal offenders.
Eur. Neuropsychopharmacol. 2002, 12, 135–140.
33. Parsian, A.; Racette, B.; Zhang, Z.H.; Rundle, M.; Perlmutter, J.S. Association of variations in
monoamine oxidases A and B with Parkinson’s disease subgroups. Genomics 2004, 83, 454–460.
34. Paris, J.; Zweig-Frank, H.; Ying Kin, N.M.K.N.; Schwartz, G.; Steiger, H.; Nair, N.P.V.
Neurobiological correlates of diagnosis and underlying traits in patients with borderline
personality disorder compared with normal controls. Psychiatry Res. 2004, 121, 239–252.
35. Vindis, C.; Séguélas, M.H.; Bianchi, P.; Parini, A.; Cambon, C. Monoamine oxidase B induces
ERK-dependent cell mitogenesis by hydrogen peroxide generation. Biochem. Biophys. Res. Commun.
2000, 271, 181–185.
36. Carpéné, C.; Daviaud, D.; Boucher, J.; Bour, S.; Visentin, V.; Grès, S.; Duffaut, C.; Fontana, E.;
Testar, X.; Saulnier-Blache, J.S.; et al. Short- and long-term insulin-like effects of monoamine
oxidases and semicarbazide-sensitive amine oxidase substrates in cultured adipocytes. Metabolism
2006, 55, 1397–1405.
37. Rommelspacher, H.; Meier-Henco, M.; Smolka, M.; Kloft, C. The levels of norharman are high
enough after smoking to affect monoamineoxidase B in platelets. Eur. J. Pharmachol. 2002, 441,
115–125.
38. Petzer, J.P.; Castagnoli, N., Jr; Schwarzschild, M.A.; Chen, J.F.; Schyf, C.J.V.D. Dual-target-directed
drugs that block monoamine oxidase B and adenosine A2A receptors for Parkinson’s disease.
Neurotherapeutics 2009, 6, 141–151.
39. Rahman, M.A. Chalcone: A valuable insight into the recent advances and potential
pharmacological activities. Chem. Sci. J. 2011, 2011, CSJ-29.
40. Green, A.L.; El Hait, M.A.S. p-Methoxyamphetamine, a potent reversible inhibitor of type-A
monoamine oxidase in vitro and in vivo. J. Pharm. Pharmacol. 1980, 32, 262–266.
Sample Availability: Samples of the compounds are available from the authors.
© 2012 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article
distributed under the terms and conditions of the Creative Commons Attribution license
(http://creativecommons.org/licenses/by/3.0/).